These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 6100876
1. Converting enzyme inhibitors normalize the reduced adrenal responsiveness to angiotensin II in essential hypertension. Williams GH, Hollenberg NK. J Hypertens Suppl; 1984 Dec; 2(2):S43-7. PubMed ID: 6100876 [Abstract] [Full Text] [Related]
5. The adrenal receptor for angiotensin II is altered in essential hypertension. Williams GH, Hollenberg NK, Moore TJ, Swartz SL, Dluhy RG. J Clin Invest; 1979 Mar; 63(3):419-27. PubMed ID: 219037 [Abstract] [Full Text] [Related]
7. Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension. Wisgerhof M, Brown RD. J Clin Invest; 1978 Jun; 61(6):1456-62. PubMed ID: 659608 [Abstract] [Full Text] [Related]
8. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus. Price DA, De'Oliveira JM, Fisher ND, Williams GH, Hollenberg NK. Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494 [Abstract] [Full Text] [Related]
10. Angiotensinogen genotype predicts abnormal renal hemodynamics in young hypertensive patients. Patel TV, Williams GH, Fisher ND. J Hypertens; 2008 Jul; 26(7):1353-9. PubMed ID: 18551010 [Abstract] [Full Text] [Related]
11. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension]. Posadas C, Sánchez G, Boyer JL, Delmar M, Serrano PA. Arch Inst Cardiol Mex; 1982 Jul; 52(4):295-300. PubMed ID: 6291470 [Abstract] [Full Text] [Related]
12. Dysregulation of aldosterone secretion and its relationship to the pathogenesis of essential hypertension. Williams GH, Moore TJ, Hollenberg NK. Endocrinol Metab Clin North Am; 1991 Jun; 20(2):423-47. PubMed ID: 1879402 [Abstract] [Full Text] [Related]
13. Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives. Redgrave J, Rabinowe S, Hollenberg NK, Williams GH. J Clin Invest; 1985 Apr; 75(4):1285-90. PubMed ID: 2985655 [Abstract] [Full Text] [Related]
14. Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition. Tokita Y, Franco-Saenz R, Mulrow PJ. Am J Hypertens; 1995 Oct; 8(10 Pt 1):1031-9. PubMed ID: 8845072 [Abstract] [Full Text] [Related]
15. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition. Guidi E, Hollenberg NK. J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668 [Abstract] [Full Text] [Related]
16. Effect of exogenous angiotensin II infusion after one year of captopril therapy in essential hypertension. Ruilope LM, Miranda B, Robles RG, Hammond TG, Sancho J, Romero JC, Rodicio JL. Postgrad Med J; 1986 Dec; 62 Suppl 1():90-3. PubMed ID: 3534868 [Abstract] [Full Text] [Related]
17. Converting-enzyme inhibition corrects the altered adrenal response to angiotensin II in essential hypertension. Taylor T, Moore TJ, Hollenberg NK, Williams GH. Hypertension; 1984 Dec; 6(1):92-9. PubMed ID: 6198274 [Abstract] [Full Text] [Related]
18. Angiotensin and the renal circulation in hypertension. Hollenberg NK, Williams GH. Circulation; 1988 Jun; 77(6 Pt 2):I59-63. PubMed ID: 3286047 [Abstract] [Full Text] [Related]
19. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats. De Godoy MA, Rattan S. J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368 [Abstract] [Full Text] [Related]